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The	 characterization	 of	 protein-nanoparticle	 assemblies	 in	 solution	 remains	 a	 challenge.	We	 demonstrate	 a	 technique	
based	 on	 a	 graphene	 microelectrode	 for	 structural-functional	 analysis	 of	 model	 systems	 composed	 of	 nanoparticles	
enclosed	in	open-pore	and	closed-pore	ferritin	molecules.	The	method	readily	resolves	the	difference	in	accessibility	of	the	
enclosed	 nanoparticle	 for	 charge	 transfer	 and	 offers	 the	 prospect	 for	 quantitative	 analysis	 of	 pore-mediated	 transport	
shed	light	on	the	spatial	orientation	of	the	protein	subunits	on	the	nanoparticle	surface,	faster	and	with	higher	sensitivity	
than	conventional	catalysis	methods.	
Introduction	
The	 ability	 to	 attach	 functional	 biomolecules	 to	 nanoparticle	
surfaces	 has	 spurred	 development	 of	 nano-therapeutic1,	
diagnostic,2	 and	 biosensing3,	 4	 agents,	 as	 well	 as	 novel	 nano-
structures5	and	devices.6	Methods	 for	 controlling	 the	number	
and	 orientation	 of	 oligonucleotides	 and	 peptides	 at	
nanoparticle	 surfaces	 have	 been	 established,6	 but	 it	 remains	
challenging	 to	 create	 nanoparticle-protein	 assemblies	 with	
native-like	 protein	 structure	 and	 function.7,	 8	 One	 emerging	
paradigm	 is	 a	 thermophilic	 ferritin	 protein9,	 10	whose	 24	 self-
assembling	 four-helix	 bundles	 maintain	 native	 stoichiometry	
and	 secondary	 structure	 when	 encapsulating	 a	 single	 6-nm	
gold	 nanoparticle	 (AuNP).11-13	 However,	 the	 assembly	
configuration	 in	 solution	 remains	 unknown	 because	
conventional	 methods	 for	 characterizing	 protein	 structure,	
such	 as	 X-ray	 crystallography,14	 are	 not	 suitable	 for	 liquid-
phase	protein-nanoparticle	conjugates.	
Here,	 we	 demonstrate	 a	 non-perturbing	 method	 using	 a	
graphene	microelectrode15	for	structural-functional	analysis	of	
an	 ordered	 AuNP-ferritin	 protein	 assembly	 that	 differs	
substantively	 from	 an	 unstructured	 protein	 corona.	 Charge	
flowing	from	the	AuNP	through	ferritin	pores	transfers	into	the	
graphene	microelectrode	and	 is	 recorded	by	an	electrometer.	
The	measurements	are	consistent	with	a	pore	diameter	of	4.5-
nm,	 providing	 evidence	 that	 ferritin	 maintains	 native-like	
quaternary	 structure	 upon	 AuNP	 encapsulation.	 This	 work	
highlights	 the	 design	 and	 characterization	 of	 nanoparticle-
protein	 assemblies	 with	 tunable	 ionic	 conductivity	 and	
chemical	 reactivity,	 and	 demonstrates	 a	 new	 tool	 for	
sensitively	probing	protein-nanomaterial	interactions.	
Results	and	Discussion	
Ferritin	 is	 a	 multimeric	 iron-storage	 protein	 comprising	 24	
protein	 subunits	 that	 self-assemble	 to	 form	 a	 hollow,	 ~8	 nm	
inner	 diameter	 cage.	 The	 Archaeoglobus	 fulgidus	 ferritin	
(AfFtn)	 used	 here	 is	 a	 unique	 archaeal	 ferritin	 that	 forms	 a	
tetrahedral	 arrangement	 of	 its	 four-helix-bundle	 subunits,	
yielding	 four	 wide	 (4.5-nm),	 triangular	 pores	 spanning	 the	 2-
nm	 protein	 shell16	 (Fig.	 1a).	 Stoichiometric	 addition	 of	 6-nm	
gold	nanoparticles	(AuNPs)	to	disassembled	apo-AfFtn	induces	
AfFtn	 assembly	 around	 individual	 AuNPs	 capped	 with	 bis(p-
sulfonatophenyl)phenylphosphine	 (BSSP),11-13	 while	
maintaining	 its	 native	 thermal	 stability,	 stoichiometry,	
ferroxidase	 activity,	 and	 secondary	 structure.11	 However,	 it	 is	
not	 understood	 whether	 AfFtn	 assembles	 in	 its	 native	
quaternary	 structure	 upon	 AuNP	 encapsulation,	 maintaining	
the	 large	 triangular	pores,	or	whether	 subunits	assemble	 in	a	
more	typical	ferritin	closed-pore	conformation	or	adsorb	in	an	
unordered	fashion.	
		
A	 graphene	microelectrode	was	used	 to	quantify	 Faradaic	
current	 through	 a	 ferritin-AuNP	 assembly	 and	 thereby	 gain	
information	 about	 the	 arrangement	 of	 AfFtn	 subunits	 on	 the	
AuNP	 surface	 (i.e.	 differentiate	 between	 open-	 and	 closed-
pore	forms	of	the	AfFtn	shell).	The	experimental	setup	(Fig.	1a)	
consisted	 of	 a	 graphene-based	 microelectrode	 connected	 to	
the	 inverting	 input	of	an	electrometer15	 (Keithley	6517a).	The	
electrostatic	 potential	 above	 a	 protein	 assembly	 in	 fluid,	𝜓",	
drives	a	sub-picoampere	Faradaic	current,	i,	through	the	series	
resistance	 of	 the	 charge-transfer	 at	 the	 graphene-solution	
interface15	(𝑅$%	~	100	GΩ),	the	graphene	sheet	(𝑅☐	~	102	–	103	
Ω/☐),	 and	 the	 graphene-gold	 contact17	 (𝑅&	 ~	 10	 Ω).	
Transferred	charge	accumulates	on	the	feedback	capacitor	and	
is	 read	out	on	 the	electrometer.	Because	 there	 is	no	extrinsic	
bias	 voltage	 between	 the	 solution	 and	 the	 microelectrode,	
heat	dissipation	(aW	µm-2)	and	electrical	perturbation	(~pA)	to	
the	 protein	 structure18	 are	 minimized.	 In	 a	 previous	 report15	
we	 documented	 the	 intrinsic	 low	 noise	 level	 for	
microelectrode	measurements	 in	 an	 idealized	 buffer	 solution	
as	 well	 as	 excellent	 agreement	 between	 the	 data	 and	
theoretical	 models	 of	 the	 behaviour	 of	 the	 electric	 double	
layer	above	graphene.	
The	Faradaic	current	𝑖		 is	proportional	to	the	potential	𝜓":	𝑖 = 𝜓"/𝑅$%.	 We	 applied	 a	 phosphate	 buffer	 solution	 to	 the	
graphene	microelectrode	 and	measured	 the	 Faradaic	 current	
while	 the	 electrostatic	 potential	 above	 the	 graphene	 surface	
was	tuned	by	varying	the	buffer	ionic	strength	𝑐	(Fig.	1b).	The	
variation	 of	 𝜓" 	 with	 ionic	 strength	 was	 inferred	 from	 the	
Grahame	equation	for	the	electric	double	 layer.	The	fit	 to	the	
data	corresponds	to	a	constant	charge-transfer	resistance	𝑅$%	
=	69	±	2	GΩ,	and	the	fit	passes	through	the	origin	as	expected	
(0.6	±	0.9	fA).	
The	assembly	state	of	AfFtn	in	solution	is	affected	by	ionic	
strength:	it	assembles	into	the	native	24mer	cage	at	high	ionic	
strength	and	disassembles	 into	dimers	at	 low	ionic	strength.16	
For	quantifying	trans-pore	current	via	 the	enclosed	AuNP,	the	
current	baseline	for	the	AuNP-ferritin	system	was	determined	
by	measuring	 the	 Faradaic	 current	of	 an	AfFtn	mutant	 (E65R,	
termed	 AfFtn-R),	 which	 remains	 a	 24mer	 even	 in	 low	 ionic	
strength	 solution.	 (See	 Supplementary	 Fig.	 S1.)	 The	 solution	
(200	 µL;	 20	 nM)	 was	 applied	 to	 the	 microelectrode,	 and	 a	
sparse	layer	of	non-specifically	bound	protein	allowed	to	form	
and	equilibrate	 (Supplementary	Fig.	 S2).	As	 the	 ionic	 strength	
of	 the	 solution	was	 varied	 from	40	mM	 to	640	mM,	a	15-sec	
time	 trace	of	 Faradaic	 charge	 transfer	 (Fig.	 2a)	 for	AfFtn-R	or	
AfFtn	was	used	 to	extract	 the	corresponding	Faradaic	current	
(Fig.	 2b).	 Because	 of	 its	 excellent	 linearity,	 this	 15-sec	 time	
trace	 is	sufficient	to	determine	the	Faradaic	current	with	high	
accuracy:	 indeed,	 for	 all	 figures	 in	 this	 report,	 the	 statistical	
errors	associated	with	the	electronic	measurement	are	smaller	
than	the	size	of	the	plotted	points,	and	the	observed	scatter	in	
the	 data	 is	 ascribed	 to	 experimental	 variation	 in	 the	 biofluid	
that	 is	 difficult	 to	 control.	 The	 solutions	 showed	 nearly	
identical	 Faradaic	 current	 at	 high	 ionic	 strength	 where	 both	
ferritins	 form	 stable	 24mer	 assemblies,	 but	 the	 currents	
differed	 significantly	 at	 low	 ionic	 strength,	 where	 only	 AfFtn	
disassembles	into	dimers.	The	measured	current	for	the	AfFtn-
R	 solution	 (black	 circles	 in	 Fig	 2b)	 and	 the	 Faradaic	 current	
difference	between	the	solutions	of	AfFtn	and	AfFtn-R	(Fig.	2c)	
are	 well	 explained	 by	 models	 based	 on	 known	 properties	 of	
the	electric	double	layer	and	AfFtn	assembly.	In	particular,	we	
infer	 a	 dissociation	 constant	 for	 AfFtn	 of	 210	 ±	 60	 mM,	 in	
agreement	 the	 value	 found	 from	 liquid	 chromatography	
measurements.	(See	Supplementary	Section	2	for	details.)		
To	 assess	 the	 configuration	 of	 AfFtn	 subunits	 on	 the	
surface	 of	 an	 AuNP,	 we	 measured	 the	 real-time	 Faradaic	
charge	 transfer	 for	 solutions	 of	 AuNPs	 (𝐼AuNP,	 see	
Supplementary	Fig.	S3),	and	of	AuNP-ferritin	assemblies	based	
upon	 the	 wild-type	 ferritin	 AfFtn	 and	 a	 recently	 identified	
mutant,	 AfFtn-AA	 (K150A/R151A),	 which	 features	 an	
octahedral	arrangement	of	its	subunits	with	“closed”	(<	1	nm)	
pores.19	Representative	data	are	shown	in	Supplementary	Fig.	
S4.	 If	 AfFtn	 and	 AfFtn-AA	 maintain	 their	 native	 quaternary	
structure	upon	AuNP	encapsulation,	 the	AuNP	 surface	 should	
be	 less	 accessible	 for	AfFtn-AA	 compared	 to	AfFtn,	 and	 there	
should	therefore	be	less	charge	transfer.	
We	used	the	Faradaic	current	of	AfFtn-R	as	the	baseline	for	
assembled	 (24mer)	 ferritin,	 which	 leads	 to	 several	 strict	
requirements	for	accurate	quantification	of	trans-pore	current.	
First,	ferritin	must	remain	assembled	with	the	AuNP	enclosed.	
This	 is	 satisfied	as	24mer	assemblies	of	both	AuNP-AfFtn	 and	
AuNP-AfFtn-AA	are	stable	in	the	range	of	ionic	strengths	tested	
(40	–	340	mM).11	Second,	all	AuNPs	must	be	encapsulated	by	
ferritin	 with	 no	 free	 AuNPs	 in	 solution.	 As	 shown	 in	
Supplementary	Fig.	S5	and	S6,	more	than	99%	of	AuNPs	were	
enclosed	in	a	ferritin	protein	shell	as	confirmed	by	TEM	and	gel	
electrophoresis.	We	also	verified	that	AuNPs	were	stable	in	the	
		
range	 of	 ionic	 strengths	 used	 without	 aggregation	
(Supplementary	Fig.	S7).	
To	 quantify	 Faradaic	 current	 contributed	 by	 enclosed	
AuNPs,	we	 calculated	 the	 difference	 between	 the	 current	 for	
AuNP-AfFtn	 (AuNP-AfFtn-AA),	 𝐼AuNP-AfFtn	 (𝐼AuNP-AfFtn-AA)	 and	
the	baseline	(𝐼AfFtn-R):	∆𝐼=𝐼AuNP-AfFtn − 𝐼AfFtn-R	(𝐼AuNP-AfFtn-AA −𝐼AfFtn-R),	 with	 results	 plotted	 in	 Fig.	 3a.	 For	 AuNP-AfFtn,	 ∆𝐼	
varied	by	~0.12	pA	through	the	range	of	ionic	strength,	with	a	
minimum	 at	 ~240	 mM.	 For	 AuNP-AfFtn-AA,	 ∆𝐼	 was	 much	
smaller	 and	 essentially	 constant	 at	 -0.020	 ±	 0.005	 pA.	 For	
AuNP-AfFtn,	the	plot	of	∆𝐼	vs.	𝐼AuNP	 (Fig.	3b)	followed	a	linear	
trend	with	slope	a	=	0.59	±	0.05,	suggesting	that	the	efficiency	
of	 Faradaic	 charge	 transfer	 via	 AuNPs	 enclosed	 in	 open-pore	
AfFtn	 is	 ~60%	 of	 that	 for	 bare	 AuNPs.	 In	 contrast,	 for	 AuNP-
AfFtn-AA,	we	found	a	slope	a	=	0.03	±	0.03,	suggesting	that	the	
ferritin	 closed	pores	 completely	 suppress	 this	 charge	 transfer	
pathway.	
This	 analysis	 suggests	 that	 the	Faradaic	 current	 carried	by	
the	 ferritin-AuNP	 system	 has	 two	 components:	 i)	 pore-
mediated	current	via	the	AuNP	and	ii)	current	associated	with	
the	 protein	 shell,	 quantified	 by	 𝐼AfFtn-R.	We	 define	 the	 trans-
pore	 efficiency	 𝜉 𝑐 =a𝐼AuNP 𝑐 a𝐼AuNP 𝑐 + 𝐼AfFtn-R 𝑐 	 to	 quantify	 the	
fraction	 of	 the	 total	 current	 carried	 by	 the	 enclosed	 AuNPs.	
The	 efficiency	 increases	monotonically	 by	 ~100%	 as	 the	 ionic	
strength	 increases	 from	 40	 mM	 to	 340	 mM	 (Fig.	 3c).	 In	
contrast	 to	 molecular	 diffusion	 through	 the	 pore,	 which	 is	
driven	 by	 a	 concentration	 gradient,	 the	 Faradaic	 current	
depends	 on	 the	 gradient	 of	 the	 electrostatic	 potential.	 Thus,	
negative	 charge	 at	 the	 edge	 of	 the	 AfFtn	 pores	 can	 suppress	
the	 (negative)	 Faradaic	 current	 via	 the	 enclosed	 AuNP	 over	
length	 scales	 given	 by	 the	 Debye	 screening	 length	𝜆D 𝑛𝑚 =0.304 𝑐[𝑀].	 Thus	 we	 expect	 that	 the	 efficiency	 will	 be	
affected	 by	 ionic	 strength	 approximately	 as	 𝜉 = 𝐴 4.5 −𝑘𝜆D[nm] K	 where	𝐴	 is	 a	 factor	 scaling	 area	 to	 efficiency,	 4.5	
nm	 is	 the	 pore	 diameter	 for	 AfFtn,	 and	 𝑘	 is	 ~1.	 The	 charge-
transfer	efficiency	is	well	fit	by	this	equation	(Fig.	3c)	with	best	
fit	 value	 𝑘	 =	 1.2	 ±	 0.1.	 This	 experiment	 demonstrates	 the	
capability	 of	 graphene	 microelectrode	 measurements	 to	
differentiate	 between	 open-	 and	 closed-pore	 structures	 in	
ferritin-nanoparticle	 assemblies,	 confirms	 the	 solvent	
accessibility	of	enclosed	AuNPs,	and	provides	strong	evidence	
that	 the	 AfFtn	 pore	 maintains	 a	 native-like	 structure	 in	 the	
presence	of	the	enclosed	AuNP.	
For	 confirmation	 and	 comparison,	 we	 used	 conventional	
catalysis	 methods	 to	 differentiate	 between	 wild-type	 AuNP-
AfFtn	 and	 AuNP-AfFtn-AA:	 dehalogenation	 of	 a	 bisiodinated	
boron	dipyrromethene	derivative	 (I-BODIPY)	 and	 reduction	of	
4-nitrophenol.	More	AuNP	 surface	area	 should	be	exposed	 in	
the	 AfFtn-containing	 sample	 compared	 to	 AfFtn-AA,	 and	
should	 therefore	 have	 greater	 AuNP	 catalytic	 activity.	 The	
reactions	 were	 monitored	 by	 different	 spectroscopic	
techniques:	 an	 increase	 in	 fluorescence	 at	 507	 nm	 was	
observed	 for	 the	 I-BODIPY	 dehalogenation	 reaction,20	 and	 a	
decrease	 in	 absorbance	 at	 400	 nm	 was	 observed	 for	 the	 4-
nitrophenol	 reduction.21	 The	 mechanism	 for	 AuNP-catalyzed	
dehalogenation	 of	 I-BODIPY	 is	 not	 well-understood	 but	
appears	to	be	pseudo-zero	order	based	on	our	data,	similar	to	
what	 was	 observed	 for	 dehalogenation	 of	 iodobenzene	 by	
AuNPs.22	 An	 induction	 period	 was	 observed	 in	 the	 4-
nitrophenol	 reduction,	 similar	 to	 polymer-coated	 AuNP	
systems.23-26	 This	 induction	 period	 has	 been	 attributed	 to	
diffusion	 of	 reagents	 to	 the	 AuNP	 surface	 and	 surface	
rearrangement	 of	 the	 AuNP	 before	 reaction	 can	 occur.24	We	
expect	similar	effects	to	be	in	play	for	our	AfFtn-coated	AuNPs.	
As	shown	in	Fig.	4a,	the	rate	of	increase	in	the	fluorescence	
intensity	 in	 the	 AuNP-AfFtn	 solution	 (0.0081	 ±	 0.0002	
A.U./min)	 is	 approximately	 4	 times	 larger	 than	 the	 AuNP-
AfFtn-AA	 solution	 (0.0019	 ±	 0.0002	 A.U./min).	 For	 the	 4-
nitrophenol	 reduction,	 AuNP-AfFtn	 had	 roughly	 twice	 the	
catalytic	 rate	 constant,	 k	 =	 (7.4	 ±	 0.7)	 x10-3	 s-1	 vs.	 (4.0	 ±	 0.3)	
x10-3	 s-1	 for	 AuNP-AfFtn-AA	 (Fig.	 4b).	 Neither	 ferritin	
contributed	to	the	catalytic	activity;	see	Supplementary	Fig.	S8.	
For	the	catalytic	assays,	the	difference	in	signal	for	AuNP-AfFtn	
versus	AuNP-AfFtn-AA	 is	only	 four-fold	and	two-fold	for	the	 I-
BODIPY	and	4-nitrophenol	 reactions,	 respectively.	 In	contrast,	
the	 difference	 between	 AuNP-AfFtn	 and	 AuNP-AfFtn-AA	 for	
the	 microelectrode	 is	 nearly	 20-fold	 (Fig.	 3c).	 Thus,	 our	
methodology	 based	 on	 graphene	 microelectrode	 is	
comparatively	 rapid	 (seconds	 vs	 tens	 of	 minutes),	 has	 the	
potential	 for	 a	 quantitative	 estimate	 of	 the	 pore	 diameter	
through	 direct	 charge-transfer	 measurement	 through	 the	
protein	 shell,	 and	 could	 overcome	 limitations	 in	 sensitivity	
imposed	 by	 the	 AuNP	 catalytic	 reactions.	 FInally,	 the	
electrode-based	 method	 only	 requires	 relatively	 small	
amounds	 of	 sample	 solution	 (~	 tens	 of	 μL)	 compared	 to	 the	
catalytic	 method,	 which	 also	 requires	 signficant	 amounts	 of	
additional	reagents	(I-BODIPY,	4-nitrophenol,	and	NaBH4).	
Conclusions	
We	 have	 developed	 a	 graphene	 microelectrode	 device	 as	 a	
sensitive	 tool	 for	 structure-function	 analysis	 of	 AuNP-ferritin	
assemblies	in	solution.	This	all-electronic	method	has	multiple	
advantages	 for	 identifying	 protein	 pores	 compared	 to	
conventional	AuNP	catalysis	methods,	and	it	has	the	potential	
to	 be	 developed	 into	 a	 direct	 measurement	 of	 the	 pore-
mediated	charge-transfer	process.	Our	approach	could	provide	
a	 way	 to	 explore	 protein	 structure	 at	 nm-scale	 and,	 more	
broadly,	to	explore	interactions	of	biomolecules	with	inorganic	
nanomaterials	 in	 complex	 biofluids--systems	 shown	 to	 offer	
		
significant	 promise	 in	 bio-imaging,	 sensing,4	 catalysis	 and	
templated	nanoparticle	synthesis.7	
Methods	
Graphene	growth.	Copper	foil	(99.8%	purity)	was	loaded	into	a	
four-inch	quartz	tube	furnace	and	annealed	for	30	min	at	1050	
°C	 in	 ultra-high-purity	 (99.999%)	 hydrogen	 atmosphere	 (flow	
rate	80	sccm;	pressure	850mT	at	the	tube	outlet)	 for	removal	
of	 oxide	 residues.	 Graphene	 was	 deposited	 by	 low-pressure	
chemical	vapor	deposition	(CVD)	using	methane	as	a	precursor	
(flow	rate	45	sccm)	at	1050	°C	for	60	min.	
Graphene	 device	 fabrication.	 The	 graphene-copper	 growth	
substrate	 was	 coated	 with	 500-nm	 layer	 of	 poly(methyl	
methacrylate)	(PMMA,	MicroChem),	and	the	PMMA-graphene	
film	was	 floated	off	 the	surface	by	 immersion	 in	0.1	M	NaOH	
solution	 with	 the	 graphene-copper	 growth	 substrate	
connected	 to	 the	 cathode	 of	 a	 power	 supply.	 The	 PMMA-
graphene	 film	 was	 transferred	 onto	 a	 300	 nm	 SiO2/Si	 wafer	
with	 an	 array	 of	 5	 nm/40	 nm	 Cr/Au	 contact	 electrodes	 that	
were	 previously	 fabricated	 using	 photolithography.	 Al2O3	 (5	
nm)	 was	 deposited	 on	 the	 whole	 wafer	 as	 a	 sacrificial	 layer,	
and	50	µm	×	100	µm	graphene	microelectrodes	were	defined	
by	photolithography	with	photoresist	 PMGI	 (MicroChem)	 and	
S1813	 (MICROPOSIT)	 and	 oxygen	 plasma	 etching.	 The	 Al2O3	
layer	on	top	of	the	microelectrode	areas	was	removed	by	the	
basic	 photoresist	 developer	 MIF-319	 (MICROPOSIT).	 After	
removal	of	 the	photoresist	 residues	with	1165	 (MICROPOSIT),	
another	 passivation	 layer	 of	 photoresist	 SU-8	 (MicroChem)	
was	 applied	 to	 the	 device,	 and	 the	 wells	 exposing	 the	
microelectrodes	were	defined	via	photolithography.	
Computational	 Design	 of	 AfFtn-R.	 The	 crystal	 structure	 of	
wild-type	 AfFtn	 (PDB	 1SQ3)	 reveals	 a	 trimeric	 interface	 lined	
with	negatively	 charged	amino	acids.	We	hypothesized	 that	a	
high	 ionic	 strength	 solution	 allows	 for	 assembly	 by	 shielding	
the	electrostatic	 repulsion	between	subunits	at	 this	 interface.	
Therefore,	 a	 point	 mutation	 that	 inserts	 a	 positive	 charge	
along	the	interface,	with	potential	for	forming	salt	bridges	to	a	
neighboring	 subunit,	 could	 stabilize	 the	 24mer	 cage	 at	 low	
ionic	strengths.	
We	 employed	 the	 statistical	 computational	 aided	 design	
strategy	to	guide	the	selection	of	stabilizing	point	mutations.27-
30	Calculations	were	carried	out	using	atomic	coordinates	from	
chains	 G,	 H	 and	 J	 of	 AfFtn	 in	 PDB	 structure	 1S3Q2.	 For	 each	
calculation,	 all	 amino	 acids	 were	 considered	 at	 the	 site	
selected,	except	for	cysteine	and	proline.	All	other	sites	other	
than	 the	 site	 of	 interest	 were	 constrained	 to	 the	 wild-type	
identity	 and	 crystal	 structure	 conformation.	 Side-chain	
conformational	states	were	taken	from	a	rotamer	 library,	and	
all	possible	conformations	were	considered.31	Hydrogen	atoms	
were	 placed	 according	 to	 the	 CHARMM19	 topology	 files.32	
Energies	were	 calculated	 using	 the	 CHARMM19	dihedral,	 van	
der	 Waals,	 and	 electrostatic	 terms	 were	 considered,	 with	 a	
non-bonded	 cut-off	 of	 8	 Å.	 Amino	 acid	 probability	 profiles	
were	generated	by	summing	the	rotamer	probabilities	of	each	
amino	acid	type.	
Sites	34	and	65	of	AtFtn	are	at	 the	center	of	 the	carboxylate-
rich	 pore.	 Analysis	 of	 these	 sites	 using	 the	 statistical	
computational	 design	 strategy	 recovered	 wild-type	 (glutamic	
acid,	E)	as	 the	most	probable	amino	acid	at	site	34.	The	most	
probable	conformation	possesses	a	 favorable	 interaction	with	
a	neighboring	positively	charged	lysine	residue	at	site	39.	This	
site	 was	 not	 selected	 for	 mutation.	 At	 site	 65,	 the	 positively	
charged	arginine	 (R)	was	 the	most	probable	 residue.	This	 site	
was	 chosen	 for	mutation,	 and	 the	 arginine	 variant	 E65R	was	
selected	for	expression.	
Ferritin	 mutagenesis.	 The	 pAF0834	 plasmid	 containing	 the	
AfFtn	gene	was	provided	by	the	laboratory	of	Dr.	Eric	Johnson	
at	the	California	Institute	of	Technology.	AfFtn-R	was	made	by	
site-directed	 mutagenesis	 using	 the	 Stratagene	 QuikChange	
kit.	 The	 primers	 were	 obtained	 from	 Integrated	 DNA	
Technologies:	 sense	 (5ʹ-3ʹ)	
GATTTCGTTTCCCGTCGCGGTGGCCGTG,	 antisense	 (5ʹ-3ʹ)	
CACGGCCACCGCGACGGGAAACGAAATC.	 The	 mutated	 cDNA	
was	 transformed	 into	 XL1-Blue	 Supercompetent	 E.	 coli	 cells	
(Stratagene)	 according	 to	 the	 manufacturer’s	 protocol.	 The	
plasmid	 was	 isolated	 using	 a	 QIAprep	 Spin	 Miniprep	 kit	
(Qiagen).	 All	 sequencing	 was	 performed	 by	 the	 University	 of	
Pennsylvania	 DNA	 Sequencing	 Facility.	 The	 AfFtn-AA	 plasmid	
was	 purchased	 from	 DNA2.0	 and	 transformed	 the	 same	 as	
AfFtn-R.	
Ferritin	 expression/purification.	 Production	 and	 purification	
of	 AfFtn	 and	 mutants	 was	 performed	 as	 previously	
published,13	 with	 some	 modifications.	 The	 plasmid	 was	
transformed	 into	 BL21-Codon	 Plus(DE3)-RP	 competent	 E.	 coli	
cells	 (Stratagene)	 in	 TB	 medium	 (1	 L	 containing	 100	 mg	
ampicillin,	 35	 mg	 chloramphenicol)	 at	 37	 °C	 with	 shaking	 at	
225	rpm	until	OD600	~0.8	was	reached.	Expression	was	induced	
with	 1	 mM	 isopropyl	 β-D-1-thiogalactopyranoside	 (IPTG,	 Lab	
Scientific)	and	incubation	at	37	°C	was	continued	for	4	h.	Cells	
were	 centrifuged	 and	 stored	 at	 -20	 °C,	 followed	 by	
resuspension	 in	 buffer	 (20	 mM	 phosphate,	 20	 mM	 NaCl,	 pH	
7.6)	 with	 an	 EDTA-free	 protease	 inhibitor	 cocktail	 tablet	
(ThermoFisher	 Scientific).	 Cell	 lysis	 was	 performed	 by	
treatment	with	 lysozyme	 (~1	mg/mL	 final	 concentration)	 and	
sonication	 (amplitude	 of	 30,	 1	 s	 on,	 1	 s	 off,	 10	 min	 total	
processing	 time).	 Cellular	 debris	 was	 removed	 by	
centrifugation	(6	krpm,	30	min,	4	°C),	and	the	supernatant	was	
treated	 with	 nuclease	 (Pierce	 universal	 nuclease,	
ThermoFisher	 Scientific)	 after	 addition	 of	 MgCl2	 to	 a	 final	
concentration	of	2	mM	for	15	min	at	 room	temperature.	The	
solution	was	heat	shocked	to	remove	most	endogenous	E.	coli	
proteins	 (10	min	 at	 80	 °C).	 After	 pelleting	 the	 precipitated	E.	
coli	 proteins	 by	 centrifugation	 (9	 krpm,	 60	 min,	 4	 °C),	 the	
supernatant	was	buffer	exchanged	to	ensure	complete	ferritin	
assembly	(2.5	M	NaCl,	2	mM	EDTA,	20	mM	phosphate,	pH	7.6),	
and	 purified	 further	 using	 size	 exclusion	 chromatography	
(HiLoad	 16/60	 column,	 GE	 Healthcare).	 The	 purity	 of	 the	
protein	 was	 determined	 to	 be	 >95%	 by	 denaturing	 PAGE	 gel	
(4-15%	 Tris-HCl,	 Mini-Protean	 TGX	 gel),	 as	 seen	 in	
Supplementary	 Fig.	 S9a.	 Protein	 concentration	 was	
determined	 using	 the	 Bio-Rad	 Protein	 Assay	 (based	 on	 the	
Bradford	 method),	 using	 bovine	 gamma	 globulin	 as	 the	
		
standard.	Proteins	were	also	characterized	by	MALDI-TOF-MS,	
TEM,	 and	 DLS	 (see	 Fig.	 S9b,	 Fig.	 S9c	 and	 Table	 S1	 in	
Supplementary	Information).	Protein	stock	solutions	were	0.22	
µm	 filtered	 and	 stored	 at	 4	 °C	 until	 use	 in	 experiments.	
Multiple	stock	solutions	of	ferritins	were	used	for	experiments	
to	ensure	reproducibility.	
AfFtn	 solution	 and	 AfFtn-R	 solution	 preparation.	 Protein	
samples	were	prepared	at	10	µM	concentration	 in	phosphate	
buffer	 (20	 mM	 phosphate,	 pH	 7.6),	 using	 NaCl	 to	 vary	 ionic	
strength	 (40,	 90,	 140,	 190,	 240,	 340,	 440,	 540,	 640	mM).	 To	
ensure	 accurate	 ionic	 strengths,	 samples	 were	 buffer	
exchanged	 on	 a	 Zebaspin	 column	 (ThermoFisher	 Scientific)	
equilibrated	 with	 the	 appropriate	 buffer.	 Samples	 were	
incubated	overnight	at	4	°C	to	allow	for	equilibration.	
AuNP-AfFtn	 solution	 and	 AuNP-AfFtn-AA	 solution	
preparation.	 Citrate-capped	 6-nm	 AuNPs	 were	 purchased	
from	 TedPella.	 The	 citrate	 was	 exchanged	 for	 bis(p-
sulfonatophenyl)phenylphosphine	 (BSPP,	 Strem	 Chemicals)	 as	
described	 previously.33	 For	 device	 measurements,	 1	 mL	
samples	 were	 prepared	 at	 0.3	 mg/mL	 protein,	 0.6	 µM	 6-nm	
AuNP-BSPP	 in	 20	 mM	 phosphate	 pH	 7.6	 and	 equilibrated	 at	
room	 temperature	 for	 48	 h	 with	 gentle	 agitation	 to	 ensure	
encapsulation.	Protein	NP	samples	were	buffer-exchanged	into	
various	 ionic	 strengths	 (40,	90,	140,	190,	240,	340	mM)	using	
10DG	 columns	 (Bio-Rad)	 equilibrated	 with	 the	 appropriate	
phosphate	 buffer.	 The	 10DG	 column	 also	 helped	 ensure	 that	
only	 encapsulated	 AuNPs	 remained	 in	 the	 samples,	 as	
confirmed	 by	 TEM	 and	 native	 gel	 electrophoresis	 (see	
Supplementary	 Fig.	 S5	 and	 S6).	 The	 first	 two	 fractions	 were	
combined,	 and	 AuNP	 concentration	 was	 verified	 by	 UV-vis	
spectroscopy.	 Because	 bare	 AuNPs	 cannot	 elute	 on	 a	 10DG	
column,	 buffer	 exchange	 for	 the	 AuNP	 samples	 without	
protein	was	done	using	 Zebaspin	 columns	equilibrated	at	 the	
same	 ionic	 strengths.	 All	 samples	 were	 diluted	 to	 2	 mL	 to	
match	 the	 lowest	 concentration	 sample	 (20	 nM).	 All	 samples	
were	 measured	 on	 the	 same	 device	 on	 the	 same	 day	 they	
were	prepared,	to	minimize	bulk	AuNP	aggregation.	
Preparation	of	I-BODIPY.	I-BODIPY	was	prepared	following	the	
method	of	Zuber	et	al.34	A	dark	red	solid	product	was	obtained	
with	 a	mass	 of	 31.8	mg	 (69.7%	 yield).	 1H	NMR	 (CD2Cl2):	 7.54	
(3H,	m),	7.29-7.28	(2H,	m),	2.62	(6H,	s),	1.40	(6	H,	s).	Mass	was	
verified	using	MALDI-TOF-MS	with	α-cyano-4-hydroxycinnamic	
acid	 (CHCA)	 as	 matrix.	 For	 characterization	 data,	 see	
Supplementary	Fig.	S10.	
Fluorescence	 measurements.	 For	 the	 AuNP-catalyzed	
dehalogenation	 reaction,	 10	 nM	 AuNP-AfFtn	 and	 1	 µM	 I-
BODIPY	were	mixed	 in	50	mM	HEPES	buffer	 (pH	7.0).	 Steady-
state	 fluorescence	was	monitored	using	 a	Varian	Cary	 Eclipse	
fluorimeter,	 with	 PMT	 detector	 voltage	 at	 800	 V,	 excitation	
wavelength	of	465	nm,	and	temperature	of	25	°C.	
4-Nitrophenol	 reduction.	A	solution	of	5	nM	AuNP-AfFtn	and	
50	µM	 4-nitrophenol	 (Fluka)	 was	mixed	 in	 a	 cuvette.	 Freshly	
prepared	 aqueous	 NaBH4	 (Fluka)	 was	 added	 to	 a	 final	
concentration	 of	 2.5	 mM	 and	 total	 sample	 volume	 of	 1	 mL.	
Absorbance	at	200—1100	nm	was	measured	every	15	s	at	25	
°C	 using	 an	 Agilent	 8453	 UV-visible	 spectrometer.	 To	
determine	 the	 rate	 constant	 𝑘,	 the	 data	 were	 fit	 to	 a	 first-
order	reaction,	after	subtracting	the	induction	time	(197	s):	Abs = 𝜀 𝐴 O𝑒QR%	
where	 Abs	 is	 the	 measured	 absorbance,	 𝜀	 the	 extinction	
coefficient	of	4-nitrophenol	at	400	nm	 (18000	M-1	 cm-1),	 𝐴 O	
the	 initial	 concentration	 of	 4-nitrophenol	 (50	 μM),	 and	 t	 the	
time.	
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